ACL

Australian Clinical Labs

Health Care Equipment & Services

Australian Clinical Labs is a leading provider of pathology services in Australia, offering a comprehensive range of diagnostic testing services. The company operates over 50 NATA-accredited laboratories and more than 1,200 collection centers, serving a diverse clientele. Its commitment to quality and innovation positions it as a key player in the healthcare sector.

Pathology

Healthcare

Diagnostics

Australia

Shorted

short percentage4.43%

reported shorts8.5M

shares on issue192.221M

About

website

clinicallabs.com.au

industry

Health Care Equipment & Services

address

1868-1892 Dandenong Road, CLAYTON, VIC, AUSTRALIA, 3168

Connect

Key Metrics

market cap

$482.47M

p/e ratio14.76

eps$0.17

dividend yield498.00%

More Health Care Equipment & Services Stocks

Other shorted stocks in this sector

View all stocks in this industry

Short Position Trends

Track bearish sentiment and short interest over time

Historical Price Data

View stock price movements, volume, and trading patterns

Industry & Focus

Pathology

Healthcare

Diagnostics

Australia

Laboratories

Company Overview

AI-generated company summary

Company History

Australian Clinical Labs was founded to provide high-quality pathology services across Australia. Over the years, it has expanded its operations significantly, establishing a strong presence with numerous laboratories and collection centers nationwide. The company has focused on integrating advanced technologies to enhance its diagnostic capabilities and service delivery.

Competitive Advantages

Australian Clinical Labs' competitive advantages include its extensive network of laboratories and collection centers, its commitment to quality assurance, and its integration of cutting-edge technology in pathology services.

Risk Factors

•Regulatory changes in healthcare
•Operational risks from laboratory management
•Competition from other pathology service providers

Recent Developments

Last 6 months

In the past six months, Australian Clinical Labs has focused on enhancing its digital services, including eHealth and eResults platforms, to improve service delivery and patient engagement.

Key People

Leadership team at Australian Clinical Labs

Assoc. Prof. Mirette Saad

Chair

MBBS (Hons) MD (Hons) MAACB FRCPA PhD, Assoc. Prof. Saad is a registered medical practitioner with AHPRA and a Chemical Pathology Fellow at the Royal College of Pathologists of Australasia.

Dr Sudha Pottumarthy-Boddu

Director

Dr. Pottumarthy-Boddu completed her Pathology/Microbiology Fellowship training with the Royal College of Pathologists of Australasia after graduating from medical school in India.

Financial Reports

21 reports available

2025 Annual Report

Annual ReportSep 19, 2025via asx_announcements

Appendix 4E and Financial Report 30 June 2025

Annual ResultsAug 26, 2025via asx_announcements

Investor webinar - FY25 financial results

Financial ReportAug 19, 2025via asx_announcements

FY25 financial results and AGM

Financial ReportAug 5, 2025via asx_announcements

Appendix 4D and 1H25 financial statements

Half Year ResultsFeb 26, 2025via asx_announcements

1H25 financial results investor presentation

Financial ReportFeb 26, 2025via asx_announcements

1H25 financial results - investor webinar

Financial ReportFeb 17, 2025via asx_announcements

2024 Annual Report

Annual ReportSep 23, 2024via asx_announcements

Appendix 4E and FY24 financial statements

Annual ResultsAug 29, 2024via asx_announcements

FY24 financial results investor presentation

Financial ReportAug 29, 2024via asx_announcements

Showing 10 of 21 reports